D. Shaw

Clinical parameters and blood biomarkers associated with response to mepolizumab in severe asthma

Mepolizumab is effective for a subset of severe asthma patients in reducing exacerbation frequency. Identification of an early marker associated with long-term beneficial clinical response would facilitate better targeting of treatment. We set out to determine the impact of mepolizumab from a clinical, blood inflam...